View in EDS HTML Full Text PDF Full Text

Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options.

Saved in:
Bibliographic Details
Title: Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options.
Authors: Cooper, Ceinwyn G. (AUTHOR), Kafetzis, Konstantinos N. (AUTHOR), Patabendige, Adjanie (AUTHOR), Tagalakis, Aristides D. (AUTHOR)
Source: European Journal of Neuroscience. Mar2024, Vol. 59 Issue 6, p1359-1385. 27p.
Subjects: Blood-brain barrier, Dementia, Drug delivery systems, Neurological disorders, Drug carriers, Central nervous system, Nanosatellites
Abstract: Candidate drugs targeting the central nervous system (CNS) demonstrate extremely low clinical success rates, with more than 98% of potential treatments being discontinued due to poor blood–brain barrier (BBB) permeability. Neurological conditions were shown to be the second leading cause of death globally in 2016, with the number of people currently affected by neurological disorders increasing rapidly. This increasing trend, along with an inability to develop BBB permeating drugs, is presenting a major hurdle in the treatment of CNS‐related disorders, like dementia. To overcome this, it is necessary to understand the structure and function of the BBB, including the transport of molecules across its interface in both healthy and pathological conditions. The use of CNS drug carriers is rapidly gaining popularity in CNS research due to their ability to target BBB transport systems. Further research and development of drug delivery vehicles could provide essential information that can be used to develop novel treatments for neurological conditions. This review discusses the BBB and its transport systems and evaluates the potential of using nanoparticle‐based delivery systems as drug carriers for CNS disease with a focus on dementia. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Neuroscience is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 176198097
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Cooper%2C+Ceinwyn+G%2E%22">Cooper, Ceinwyn G.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kafetzis%2C+Konstantinos+N%2E%22">Kafetzis, Konstantinos N.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patabendige%2C+Adjanie%22">Patabendige, Adjanie</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tagalakis%2C+Aristides+D%2E%22">Tagalakis, Aristides D.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Neuroscience%22">European Journal of Neuroscience</searchLink>. Mar2024, Vol. 59 Issue 6, p1359-1385. 27p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Blood-brain+barrier%22">Blood-brain barrier</searchLink><br /><searchLink fieldCode="DE" term="%22Dementia%22">Dementia</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+delivery+systems%22">Drug delivery systems</searchLink><br /><searchLink fieldCode="DE" term="%22Neurological+disorders%22">Neurological disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+carriers%22">Drug carriers</searchLink><br /><searchLink fieldCode="DE" term="%22Central+nervous+system%22">Central nervous system</searchLink><br /><searchLink fieldCode="DE" term="%22Nanosatellites%22">Nanosatellites</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Candidate drugs targeting the central nervous system (CNS) demonstrate extremely low clinical success rates, with more than 98% of potential treatments being discontinued due to poor blood–brain barrier (BBB) permeability. Neurological conditions were shown to be the second leading cause of death globally in 2016, with the number of people currently affected by neurological disorders increasing rapidly. This increasing trend, along with an inability to develop BBB permeating drugs, is presenting a major hurdle in the treatment of CNS‐related disorders, like dementia. To overcome this, it is necessary to understand the structure and function of the BBB, including the transport of molecules across its interface in both healthy and pathological conditions. The use of CNS drug carriers is rapidly gaining popularity in CNS research due to their ability to target BBB transport systems. Further research and development of drug delivery vehicles could provide essential information that can be used to develop novel treatments for neurological conditions. This review discusses the BBB and its transport systems and evaluates the potential of using nanoparticle‐based delivery systems as drug carriers for CNS disease with a focus on dementia. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of European Journal of Neuroscience is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=176198097
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ejn.16229
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 27
        StartPage: 1359
    Subjects:
      – SubjectFull: Blood-brain barrier
        Type: general
      – SubjectFull: Dementia
        Type: general
      – SubjectFull: Drug delivery systems
        Type: general
      – SubjectFull: Neurological disorders
        Type: general
      – SubjectFull: Drug carriers
        Type: general
      – SubjectFull: Central nervous system
        Type: general
      – SubjectFull: Nanosatellites
        Type: general
    Titles:
      – TitleFull: Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cooper, Ceinwyn G.
      – PersonEntity:
          Name:
            NameFull: Kafetzis, Konstantinos N.
      – PersonEntity:
          Name:
            NameFull: Patabendige, Adjanie
      – PersonEntity:
          Name:
            NameFull: Tagalakis, Aristides D.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 03
              Text: Mar2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 0953816X
          Numbering:
            – Type: volume
              Value: 59
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: European Journal of Neuroscience
              Type: main
ResultId 1